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Purpose: To report a new familial case of the recently described autosomal recessive syndrome of nanophthalmos-retinitis
pigmentosa-foveoschisis-optic disc drusen, which arises from compound heterozygosity for Membrane Frizzled-Related
Protein (MFRP) mutations in a sibling pair of Mexican origin.
Methods: Ophthalmological assessment included slit-lamp and dilated fundus examination, applanation tonometry,
fundus photography, A-mode and B-mode ultrasound examination, electroretinogram, fluorescein retinal angiography,
optical coherence tomography, and electrooculogram in both affected siblings. Molecular genetic analysis consisted of
PCR amplification and direct automated sequence of the complete coding region of the MFRP gene. In addition, allele-
specific cloning and sequencing techniques were used to characterize a heterozygous MFRP frameshift mutation.
Results: Clinical examination revealed high hyperopia of > +16 diopters while electroretinographic and fluorangiographic
studies  demonstrated  a  retinal  dystrophy  compatible  with  retinitis  pigmentosa.  Ultrasound  examination  showed
nanophthalmos (eye axial length <15 mm) and optic disc drusen while optical coherence tomography evidenced cystoid
macular edema. Nucleotide sequencing in DNA from both affected siblings disclosed the presence of two  MFRP
mutations: a novel heterozygous point mutation predicting a nonsense change from tyrosine (TAC) to a stop signal (TAA)
at codon 317, and a heterozygous 1 bp deletion in exon 5, predicting a prematurely truncated protein (p.Asn167ThrfsX25).
Discussion: The third known family with the syndrome of nanophthalmos-retinitis pigmentosa-foveoschisis-optic disc
drusen is presented. This is the first demonstration of compound heterozygosity for MFRP mutations as the source of the
disease. The affected siblings described here are the youngest patients with the disease reported to date and the comparison
of their clinical data with previous individuals with this syndrome suggest that some aspects of the phenotype are probably
age-dependent.
The  complex  of  nanophthalmos-retinitis  pigmentosa-
foveoschisis-optic  disc  drusen  is  a  distinct  autosomal
recessive entity recently identified in two unrelated families
from  Mexico  and  Spain [1,2].  The  complex  is  caused by
homozygous  truncating  mutations  in  Membrane Frizzled-
Related  Protein  (MFRP),  a  gene  located  at   chromosome 
11q13  that   encodes  a  membrane   receptor  protein   highly 
expressed  in  retinal tissue which plays a potential role in the 
WNT pathway [3]. The two described families have distinct 
homozygous   mutations,   yet  both  have  presented  with a 
strikingly   similar   phenotype   characteristically   affecting 
structures  located  at  the   posterior   pole  of  the   eye   [2]. 
Nanophthalmos, an anomaly in which eyes have a short axial 
length  (13–18.5  mm),   causes  high  hyperopia,  typically 
ranging     between     +8.00    to     +25.00     diopters    [4]. 
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Secondary  glaucoma  due to  shallow anterior  chamber is a 
frequent finding in patients with this condition [5-7].
This syndrome has emerged as a novel form of syndromic
retinitis  pigmentosa  with  progressive  photoreceptor
dysfunction initiating typically at the second or third decade
of life. Both familial cases currently known carry homozygous
frameshift  mutations  at  MFRP  exon  5,  predicting  the
introduction  of  premature  stop  codons  [1,2].  Previously,
MFRP  mutations  were  identified  in  subjects  with
nanophthalmos  and  high  hyperopia  but  without  retinal
dysfunction  [8].  It  is  still  not  known  why  some  MFRP
mutations cause isolated nanophthalmos, while others trigger
the  nanophthalmos-retinitis  pigmentosa-foveoschisis-optic
disc drusen complex.
In this work, we describe the clinical and genetic features
of a new familial case of the syndrome of nanophthalmos-
retinitis pigmentosa-foveoschisis-optic disc drusen in which
two distinct MFRP mutations, including a novel nonsense
change, were demonstrated. The study participants presented
here are the youngest reported to date with the syndrome. Our
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1794study findings suggest that some aspects of the phenotype are
probably age-dependant. This is the first demonstration of
compound  heterozygosity  as  the  source  of  this  unusual
syndromic form of microphthalmos and retinitis pigmentosa.
METHODS
Clinical studies: Two sibs were studied: Ophthalmological
examinations included best-corrected visual acuity (BCVA),
slit-lamp  and  dilated  fundus  examination,  applanation
tonometry,  fundus  photography,  A-mode  and  B-mode
ultrasound  examination  (US),  electroretinogram  (ERG),
fluorescein  retinal  angiography  (FA),  optical  coherence
tomography  (OCT),  and  electrooculogram.  Affected
participants  also  underwent  systemic  evaluation  (not  only
ocular examination, but also complete physical examination
was performed) by a geneticist. The patients were recruited
from the Department of Retina of our institution (Institute of
Ophthalmology “Conde de Valenciana”) and belonged to a
Mexican  Mestizo  family  from  the  central  region  of  the
country. No consanguinity was recorded among their parents,
who had no vision abnormalities. The patients were the only
two siblings from this marriage.
Molecular  genetic  analyses:  The  two  affected  siblings
participated in the study after providing informed consent.
The study protocol was approved by the Institutional Review
Board. Genomic DNA was obtained in both participants from
peripheral blood lymphocytes according to standard methods
[9]. The entire coding sequences and exon-intron boundaries
of MFRP (located at 11q23, 13 exons) were amplified by PCR
using pairs of primers derived from the normal published
sequences (Ensembl sequence ENST00000261980). Primer
sequences and annealing temperatures  for  PCR  are  shown
in    Table 1.   Direct    sequencing    of    PCR    amplified
products was performed using the Big Dye Terminator Cycle
Sequencing kit (Applied Biosystems, Foster City, CA), with
about 10 ng of template DNA added to each reaction. Samples
were run in an ABI Prism 310 Genetic Analyzer (Applied
Biosystems).  Sequences  were  compared  manually.
Additionally,  an  allele-specific  cloning  and  sequencing
approach  was  used  to  precisely  characterize  a  MFRP
frameshift mutation. Briefly, new MFRP exon 5 products
were amplified from genomic DNA, gel-purified, ligated by
means of a TA-ligation method into the TA-cloning vector
pGEM-T (Promega, Madison, WI), and subcloned into DH5α
E.  coli  competent  cells  (Invitrogen,  Carlsbad,  CA)  as
previously  described  [10].  The  plasmid  inserts  were
sequenced by following the aforedescribed protocol and by
using the forward pUC/M13 primer.
RESULTS
Patient #1: An 18-year-old girl, patient #1 had a BCVA of
20/200 and refractive error of +16.75 OU. In both eyes, her
intraocular pressure was 12 mmHg, normal horizontal corneal
diameters  (11.5  mm),  and  no  anterior  chamber  angle
anomalies.  This  patient  had  progressive  nyctalopia  and
decreasing  visual  acuity  since  infancy.  Funduscopic
examination disclosed very small optic cups (<20%), cystic
lesions on macular areas, diminished foveal reflex in both
eyes, and retinal pigmented epithelium (RPE) mottling and
atrophy mainly at posterior pole and peripheral retina in both
eyes  (Figure  1A).  There  was  no  clinical  evidence  of
retinoschisis. FA showed transmission defects corresponding
to the observed mottled areas of RPE atrophy (Figure 1B).
ERG showed abolished scotopic light response in both eyes
while photopic response was recordable but subnormal OU.
The Arden ratio was 144% OD and 108% OS (normal values:
TABLE 1. PCR PRIMERS FOR MFRP GENE AMPLIFICATION
Exon Oligonucleotide sequence (5′-3′) Annealing temperature (°C) PCR product size (bp)
1–4 F GGTCTTGGGCTGTCACAGG 60.3 843
1–4 R CCACCCCGTCATCTTGGGC
2 R CCTTCTGTTGGGTATTCCTC (for sequencing only)
5 F CTTGAGAATAAAGGACCTCA 59.5 327
5 R CTTTAGATAGTGGTTCAGGA
6 F ATAGGACTGCAAGGCCCAGG 58.7 287
6 R CCTTTGACAGGACTGGGAGT
7–8 F ACTCCCAGTCCTGTCAAAGG 59.2 582
7–8 R TTCCCATTACACTAACTTGG
9 F TTAAGAACCACCAATGATG 54.6 370
9 R TGGAGAATGGAATGTGCTGG
10 F AGCTCAGAGCCAGGCCTGT 58.2 264
10 R CCTGGAGGTGCCTCTACT
11 F GGACAGACAAGGGCTCTGGA 59.1 304
11R ACTGTGCAGTACGGCAGTAGG
12 F ATTCGGTGACTTGCCACAGG 59.1 581
12 R TTGTTCCCCTGCGTGCCAGC
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1795180%–200%). Ultrasonographic examination demonstrated
eye axial length of 14.79 mm (OD) and 14.65 mm (OS), but
it showed optic nerve drusen and thickened choroid in both
eyes. OCT imaging revealed increased foveal thickness that
was  331  μm  OD  and  317  μm  OS.  OCT  also  showed
hyporeflective images of cystic appearance, and splitting of
inner retinal layers.
Patient #2: The 16 year-old brother of patient #1, patient #2
presented with a BCVA of 20/200 OD and 20/100 OS. In both
eyes, he had a refractive error of +16.75 OU, intraocular
pressure of 12 mmHg, normal horizontal corneal diameters
(11.5 mm), and no anterior chamber angle anomalies. Like his
sister, this patient had progressive nyctalopia and decreasing
visual acuity since infancy. He had also cystic lesions on
macular areas, diminished foveal reflexes, and RPE mottling
and atrophy mainly at posterior pole and peripheral retina in
both eyes. Also in both eyes, he had cystic lesions on macular
area, diminished foveal reflex, and RPE mottling and atrophy
mainly at posterior pole and peripheral retina. There was no
clinical  evidence  of  retinoschisis.  FA  showed  diffuse
transmission defects corresponding to the observed areas of
RPE mottling and atrophy. ERG demonstrated a subnormal
scotopic light response in OD and an abolished response in
OS. OCT imaging revealed this patient had increased foveal
thickness  of  399  μm  OD  and  409  μm  OS,  as  well  as
hyporeflective  images  of  cystic  appearance,  and  apparent
splitting of inner retinal layers (Figure 1C). The Arden ratio
was 122% OD and 116% OS. Ultrasonography revealed his
eye axial length was 14.93 mm OD, and 14.67 mm OS. He
had optic nerve drusen and thickened choroids in both eyes.
Molecular genetic findings: Nucleotide sequence in DNA
from both affected siblings disclosed the presence of two
MFRP mutations: a heterozygous 1-bp deletion (c.498delC)
in exon 5 (Figure 2A,B), predicting a prematurely truncated
protein  (p.Asn167ThrfsX25);  and  a  heterozygous  point
mutation from C to A, predicting a nonsense change from
Tyrosine (TAC) to a stop signal (TAA), at codon 317 in exon
8 (Figure 2C). This nonsense mutation has not been previously
described  while  the  c.498delC  mutation  was  recently
identified by Crespi et al. [2] in a familial case in Spain of the
nanophthalmos-retinitis pigmentosa syndrome.
DISCUSSION
Nanophthalmos is an ocular anomaly characterized by the
combination of microphthalmos, microcornea, and a tendency
toward spontaneous or postsurgical uveal effusions [11,12].
Nanophthalmos  is  sometimes  referred  to  as  “simple
microphthalmos” [13,14]. The short distance between the lens
and retina in nanophthalmic eyes causes extreme hyperopia
with  refractive  defects  ranging  between  +8.00  to  +25.00
diopters. Typically, nanophthalmic eyes have an axial length
of 13–18.5 mm and are associated with a shallow anterior
chamber and thickening of both the choroidal vascular bed
and sclera [15-17].
In  2006,  Ayala-Ramirez  et  al.  [1]  described  the
ophthalmologic features of a Mexican family in whom four
siblings were affected by a novel autosomal recessive eye
disease characterized by posterior microphthalmos, retinitis
pigmentosa, foveoschisis, and optic disc drusen. As human
MFRP mutations result in nanophthalmos and mutations in
the orthologous Mfrp gene causes the recessive mouse retinal
Figure  1.  Eye  phenotype  in  Retinitis
pigmentosa-nanophthalmos  complex.
A: Fundus photograph of the right eye
from  patient  #1  reveals  optic  disc
drusen,  diffuse  retinal  pigment
epithelium atrophy, and blunting of the
macular  reflex.  B:  Fluorescein
angiography  shows  choroidal
transmission  hyperfluorescence
corresponding  to  retinal  pigment
epithelium  atrophy  (patient  #1,  right
eye).  C:  OCT  image  demonstrates
cystoid  macular  edema,  inner  retinal
layers  splitting  with  discrete  bridging
elements at the fovea, and macular cysts
(patient #2, left eye).
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1796degeneration rd6, these authors searched for MFRP mutations
as  a  source  for  this  novel  phenotype.  A  homozygous
frameshift P166fsX199 mutation in MFRP segregated with
the disease in that pedigree, validating mutations at this gene
as the responsible for the phenotype [1].
The panocular phenotype observed in patients with the
nanophthalmos-retinitis  pigmentosa  complex
(microphthalmia, retinitis pigmentosa, foveoschisis, and optic
disc drusen) suggests that MFRP plays a wide role in eye
development, functioning both as a regulator of axial eye
length and as a critical molecule for photoreceptor function.
Figure  2.  MFRP  gene  mutations  in  Retinitis  pigmentosa-
nanophthalmos complex. A: Partial nucleotidic sequence of MFRP
exon 5 in DNA from patient # 1 shows a heterozygous 1 bp deletion
(c.498delC),  which  predicts  a  prematurely  truncated  protein
(p.Asn167ThrfsX25).  Compare  this  illustration  with  the  normal
sequence shown in B in which arrow points to the deleted nucleotide.
C: Partial DNA sequence of MFRP exon 8 shows a heterozygous
point mutation from C to A (arrow), predicting a nonsense change
from tyrosine (TAC) to a stop signal (TAA), at codon 317.
Recent studies in the Mfrprd6/rd6 mouse model indicate that
MFRP is necessary for photoreceptor maintenance [18].
The  affected  siblings  presented  in  this  work  are  the
youngest  described  to  date.  Several  clinical  features  are
important  to  note.  Fundus  examination  in  both  patients
revealed  multiple,  irregular,  round  yellow-white  flecks,
mainly  located  at  the  posterior  pole  retina  and  did  not
demonstrate  the  presence  of  “bone  spicule”
hyperpigmentation. The absence of this hyperpigmentation is
significant because previous reports documented its presence
in  all  patients  (seven  from  two  unrelated  families)  with
nanophthalmos-retinitis  pigmentosa  complex.  This  is  an
interesting finding as mice homozygous for rd6 have small,
evenly spaced white dots throughout their retinas that become
apparent by eight weeks of age. Homozygous rd6 mice begin
to show clinical signs of retinal degeneration at seven months
of age. By 15 months, the fundus has developed a mildly
pigmented granular and mottled appearance; individual spots
can still be seen, although less frequently, in mice up to about
two years old [19]. These data, along with our observations,
suggest that MFRP mutations in both mice and humans lead
to  a  fundus  phenotype  characteristic  of  “typical”  retinitis
pigmentosa, with retinal pigmentary changes occurring in the
form of fine mottling or granularity with surrounding areas of
atrophy in the earlier stages followed by the typical “bone-
spicule” pattern of hyperpigmentation in midperipheral retina,
at later stages.
Each participant from the original family [1] exhibited
localized foveal schisis with no clinical, fluorangiographic, or
OCT evidence of cystoid macular edema or macular cysts.
Retinal OCT in patients from the family described by Crespi
et al. [2] and in the young siblings we describe here showed
foveal cystic lesions reminiscent of cystoid macular edema.
There was, however, schisis of external retinal layers evident
in the present study’s siblings, suggesting the occurrence of
two  independent  maculopathies:  foveoschisis  and  cystoid
macular  edema.  Although  this  finding  suggests  that  it  is
probable that macular cysts leads to foveoschisis, it is also
likely that the combined effect of both nanophthalmos and
macular cysts could account for the localized foveal schisis
characteristic of this syndromic form of retinitis pigmentosa.
It is also possible that foveoschisis is a permanent sequela after
cystoid edema resolves in nanophthalmic eyes, contrary to
that  which  occurs  in  normal  sized  eyes.  Cystoid  macular
edema  is  a  frequent  finding  in  retinitis  pigmentosa  and,
according to OCT results, seems to occur in 32%–49% of
these  patients  [20,21].  Glaucoma  is  another  finding  that
suggests  there  is  an  age-dependent  component  to
nanophthalmos-retinitis  pigmentosa  complex.  While  not
observed in young or middle-aged patients in this study and
the one by Ayala-Ramirez et al. [1], glaucoma was noted in
older participants in the research performed by Crespi et al.
[2]. Further study of additional subjects of a range of ages with
this complex would help to clarify these issues.
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1797Finally, this case of MFRP compound heterozygosity
suggests that the disorder, or at least the carrier status, could
be more frequent than previously thought. We propose to
suspect the diagnosis of this complex diseases in those patients
with retinitis pigmentosa who also exhibit high refractive
errors ranging between +8.00 to +25 diopters.
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